z-logo
open-access-imgOpen Access
Why Are Patients Switching from Tenofovir Disoproxil Fumarate/Emtricitabine (Truvada) to Tenofovir Alafenamide/Emtricitabine (Descovy) for Pre-Exposure Prophylaxis?
Author(s) -
Alexa B. D’Angelo,
Drew A. Westmoreland,
Pedro B. Carneiro,
Jeremiah Johnson,
Christian Grov
Publication year - 2021
Publication title -
aids patient care and stds
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.504
H-Index - 85
eISSN - 1557-7449
pISSN - 1087-2914
DOI - 10.1089/apc.2021.0033
Subject(s) - emtricitabine , tenofovir alafenamide , pre exposure prophylaxis , medicine , tenofovir , family medicine , human immunodeficiency virus (hiv) , men who have sex with men , viral load , syphilis , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom